You are here

  • Home
  • Archive
  • Volume 76, Issue 2
  • Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

Article metrics

Article menu

Download PDFPDF

XML
Clinical and epidemiological research
Concise report
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: June 2016 to December 2021

AbstractFullPdf
Jun 2016632190258
Jul 2016535388395
Aug 2016271240211
Sep 2016126150208
Oct 2016135138104
Nov 2016112131103
Dec 20168811366
Jan 20171246231369
Feb 2017367320289
Mar 20175191105
Apr 2017519566
May 20171125479
Jun 20173216671
Jul 201719118162
Aug 201720720274
Sep 201721521282
Oct 201731731990
Nov 201723022686
Dec 201718418281
Jan 201824223196
Feb 201821719785
Mar 201821018854
Apr 201820417653
May 201818217045
Jun 201822121741
Jul 201820820659
Aug 201819219066
Sep 201815214669
Oct 201824220661
Nov 201831127274
Dec 201815913954
Jan 201920416952
Feb 201939739169
Mar 2019270254100
Apr 201920718857
May 201921319849
Jun 201917615949
Jul 201919415737
Aug 201914211231
Sep 201917513137
Oct 201918616346
Nov 201914613340
Dec 201915613444
Jan 202014713046
Feb 202013811144
Mar 202021718361
Apr 202016512086
May 20201088962
Jun 20201078250
Jul 2020776747
Aug 2020604534
Sep 20201299839
Oct 202011710554
Nov 20201127928
Dec 202012510727
Jan 202113711953
Feb 2021827342
Mar 202117813558
Apr 20211148028
May 20211059137
Jun 2021868542
Jul 2021676631
Aug 2021636344
Sep 2021838246
Oct 2021847447
Nov 2021816368
Dec 202116914836
Total12666108515277